NCT06660667 - A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

May 18, 2027

Study Completion Date

June 30, 2031

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL

SAR402663

Pharmaceutical form:Liquid formulation-Route of administration:Intravitreal injection

DRUG

Diluent

Pharmaceutical form:Liquid solution-Route of administration:Intravitreal injection

Trial Locations (12)

21740

RECRUITING

Site # 8400003, Hagerstown

32607

RECRUITING

Site # 8400004, Gainesville

33711

RECRUITING

Site # 8400002, St. Petersburg

38138

RECRUITING

Site # 8400018, Germantown

60439

RECRUITING

Site # 8400005, Lemont

75231

RECRUITING

Site # 8400006, Dallas

78705

RECRUITING

Site # 8400015, Austin

85020

RECRUITING

Site # 8400011, Phoenix

89502

RECRUITING

Site # 8400021, Reno

90211

RECRUITING

Site # 8400023, Beverly Hills

97401

RECRUITING

Site # 8400017, Eugene

02114-2517

RECRUITING

Site # 8400009, Boston